EP3502236
DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.2.2012EP published:
23.8.2023EP application number:
18208362.6
EPO information:
European Patent Register
Max expiry date:
16.2.2032
Title in English:
DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATELanguage of the patent:
English
Timeline
Today
17.2.2012EP application
23.8.2023EP Publication
Owner
Name:
The Scripps Research InstituteAddress:
Mail Drop TPC-8 10550 North Torrey Pines Road, La Jolla CA 92037, US
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
SCHULTZ, PeterAddress:
La Jolla, CA California 92037, US
Name:
LAIRSON, LukeAddress:
San Diego, CA California 92103, US
Name:
DESHMUKH, VishalAddress:
La Jolla, CA California 92037, US
Name:
LYSSIOTIS, CostasAddress:
La Jolla, California 92037, US
Priority
Number:
201161444666 PDate:
18.2.2011Country:
US
Classification
Categories:
A61K 31/135, A61K 31/137, A61K 31/138, A61K 31/216, A61K 31/40, A61K 31/439, A61K 31/46, A61K 31/495, A61K 31/5415, A61P 25/00, A61P 25/02, A61P 27/02, A61P 29/00, A61P 43/00